Is Anti–Vascular Growth Factor Therapy for Retinopathy of Prematurity Associated With Pulmonary Hypertension?

登录注册会员服务联系我们

Is Anti–Vascular Growth Factor Therapy for Retinopathy of Prematurity Associated With Pulmonary Hypertension?—Reply

Published:2023-04-01 Issue:4 Volume:141 Page:408
ISSN:2168-6165
Container-title:JAMA Ophthalmology
language:en
Short-container-title:JAMA Ophthalmol

Author:

Nitkin Christopher R.¹,Richardson Troy²,Lewis Tamorah³

Affiliation:

1. Division of Neonatology, Department of Pediatrics, Children’s Mercy Kansas City, University of Missouri Kansas City School of Medicine, Kansas City

2. Children’s Hospital Association, Lenexa, Kansas

3. The Hospital for Sick Children, Divisions of Clinical Pharmacology & Toxicology and Neonatology, University of Toronto, Toronto, Ontario, Canada

Publisher

American Medical Association (AMA)

Subject

Ophthalmology

Link

https://jamanetwork.com/journals/jamaophthalmology/articlepdf/2802118/jamaophthalmology_nitkin_2023_lr_230001_1680880079.32901.pdf

Reference3 articles.

1. Pulmonary Hypertension in Preterm Infants Treated With Laser vs Anti-Vascular Endothelial Growth Factor Therapy for Retinopathy of Prematurity.;Nitkin;JAMA Ophthalmol,2022

2. Treatment of newborn rats with a VEGF receptor inhibitor causes pulmonary hypertension and abnormal lung structure.;Le Cras;Am J Physiol Lung Cell Mol Physiol,2002

3. The critical role of vascular endothelial growth factor in pulmonary vascular remodeling after lung injury.;Lahm;Shock,2007

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP